ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,134.80
      -0.51%
      Dow Jones
      39,065.26
      -1.53%
      Brent Oil
      81.265
      -0.33%
      Bitcoin
      67,732.88
      -1.99%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Sandoz Group Ag (0SAN)

      7. Sandoz Group Ag (0SAN) News

      0SAN

      Sandoz (0SAN)

      Sandoz Group Ag
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:0SAN
      DateTimeSourceHeadlineSymbolCompany
      05/22/20241:00AMUK RegulatorySandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in EuropeLSE:0SANSandoz Group Ag
      05/07/20241:00AMUK RegulatorySandoz reports first quarter 2024 salesLSE:0SANSandoz Group Ag
      04/30/20246:25AMUK RegulatoryShareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AGLSE:0SANSandoz Group Ag
      04/30/20241:00AMUK RegulatorySandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilarsLSE:0SANSandoz Group Ag
      04/22/20241:00AMUK RegulatorySandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offeringLSE:0SANSandoz Group Ag
      03/21/20249:00AMUK RegulatorySandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicinesLSE:0SANSandoz Group Ag
      03/13/20242:00AMUK RegulatorySandoz reports fourth quarter 2023 sales and full-year 2023 resultsLSE:0SANSandoz Group Ag
      03/05/20241:24PMUK RegulatorySandoz receives FDA approval for first and only denosumab biosimilarsLSE:0SANSandoz Group Ag
      03/05/20241:00AMUK RegulatorySandoz announces nominations to the Board of Directors and leadership changeLSE:0SANSandoz Group Ag
      03/04/20241:00AMUK RegulatorySandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US marketLSE:0SANSandoz Group Ag
      02/29/20241:00AMUK RegulatorySandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffsLSE:0SANSandoz Group Ag
      02/01/20241:15AMUK RegulatorySandoz announces changes in the Board of DirectorsLSE:0SANSandoz Group Ag
      01/31/20241:00AMUK RegulatorySandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in GermanyLSE:0SANSandoz Group Ag
       Showing the most relevant articles for your search:LSE:0SAN